Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2008
03/19/2008CN101143861A B ring 4'-single substituted flavone compounds, preparation method and use
03/19/2008CN101143857A Benzoyl guanidine derivative, preparation method and medical use thereof
03/19/2008CN101143851A Ligustrazine aromatic acid ether derivatives, preparation method thereof, medicament composition and use
03/19/2008CN101143846A Metal salt of quinaprilat
03/19/2008CN101143845A Substituted quinoline formyl guanidine derivative, its preparation method and medical use
03/19/2008CN101143217A Treatment of neurological and neuropsychological disorders
03/19/2008CN101143215A Proteinase inhibitor nervous cell protecting function and application
03/19/2008CN101143200A Traditional Chinese medicine for treating acute ischemic stroke
03/19/2008CN101143190A Traditional Chinese medicine preparation for treating hemorrhoids toxic sore
03/19/2008CN101143168A Technology for preparing haw total phenolic acid part
03/19/2008CN101143164A Medicinal composition for treating coronary heart disease and preparation process thereof
03/19/2008CN101143157A Tyrosol and tyrosol bypass salidroside plant extraction and preparation and use thereof
03/19/2008CN101143140A Isosorbide mononitrate timely quick-release and slow-release preparation
03/19/2008CN101143126A Ethyl cellulose slow release system for nucleophilic NO donor medicine and its preparation method
03/19/2008CN100375755C Longleaf Grateloupia acuminata polysaccharide extract and its preparation and use
03/19/2008CN100375746C Process for preparing decumbent corydalis tuber total alkaloid and its preparation and quality detecting method
03/19/2008CN100375632C Extractive from combined vegetable drug for treating heart disease of coronary sclerosis, and method of extraction
03/19/2008CN100375625C Quick thrombolysis for apoplexy
03/19/2008CN100375612C Blood pressure lowering dripping pills with chryanthemum flower and pearl and its preparation process
03/18/2008US7345158 Cardiac failure, cardiomegaly, myocarditis, cardiomyopathy, arteriosclerosis, arteriosclerosis obliterans, or ischemic heart disease
03/18/2008US7345151 Antagonists specific for denatured collagen and methods of using same
03/18/2008US7345138 Biodegradable polyphosphates for controlled release of bioactive substances
03/18/2008US7345096 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
03/18/2008US7345079 Treatment of disorder related to low cyclic GMP levels
03/18/2008US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
03/18/2008US7345070 Side effects reduction; Diabetes mellitus, Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; 3-{4-[2-(2-phenyl-5-methyl-oxazol-4-yl)-ethoxy]-phenyl}-2-methyl-2-phenoxy-propionic acid
03/18/2008US7345067 peroxisome proliferator activators such as (2-methyl-4-{methyl-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethyl]-amino}-phenoxy)-acetic acid, used as lipid modulators and insulin sensitizers
03/18/2008US7345066 Use of thiazole derivatives for preparing a medicine for protecting mitochondria
03/18/2008US7345047 7-[7-[2-cycloalkyl]amino]-5-(propylthio)--3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]spiro[2.4]heptane-4,5,6-triol from spiro[2.4]hept-5-ene-4,7diol Diacetate and 4,6-dichloro-5-nitro-3-propylthiopyrimidine intermediates; for P2T (P2Y(ADP) or P2T(AC)) receptor antagonists; antithrombotics; unstable angina
03/18/2008US7345045 Pyrido-pyrimidine compounds as medicaments
03/18/2008US7345036 (Pyrido/thieno)—[f]—oxazepine-5-one derivatives
03/18/2008US7344705 Composition comprising low density microspheres
03/18/2008CA2401005C Methods for extraction and reaction using supercritical fluids
03/18/2008CA2394120C Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it
03/18/2008CA2355776C Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
03/18/2008CA2335015C Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
03/18/2008CA2329128C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
03/18/2008CA2327784C Triazolones with a neuroprotective action
03/18/2008CA2293705C Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride
03/18/2008CA2264739C Inhibition of nuclear transcription factor nf-kb by caffeic acid phenethyl ester (cape), derivatives of cape, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin
03/18/2008CA2219659C Rapamycin derivatives
03/18/2008CA2102494C A pharmaceutical composition containing a defined lipid system
03/13/2008WO2008030891A2 Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof
03/13/2008WO2008030579A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder
03/13/2008WO2008030520A1 Heterocyclic gpr40 modulators
03/13/2008WO2008030382A1 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
03/13/2008WO2008030369A1 Inhibitors of 5 -lipoxygenase activating protein ( flap)
03/13/2008WO2008030158A1 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors
03/13/2008WO2008029907A1 Hypertension-ameliorating agent
03/13/2008WO2008029882A1 2-alkyl-6-(pyrazolopyridin-4-yl)pyridazinone derivative, addition salt thereof, and pde inhibitor comprising the derivative or the salt as active ingredient
03/13/2008WO2008029825A1 Imidazole derivative
03/13/2008WO2008029763A1 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
03/13/2008WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action
03/13/2008WO2008029371A1 Pyridin-4-yl derivatives as immunomodulating agents
03/13/2008WO2008029370A1 Pyridin-3-yl derivatives as immunomodulating agents
03/13/2008WO2008028958A1 Cyclic sulfones useful as mitochondrial sodium-calcium exchangers
03/13/2008WO2008028617A1 Heteroaryl derivatives as protein kinase inhibitors
03/13/2008WO2008028410A1 Use of low molecular weight fucoidan in the preparation of medicament for the treatment of cardiovascular and cerebrovascular diseases
03/13/2008WO2008028405A1 Neukinase, a downstream protein of neuregulin
03/13/2008WO2008008024A9 Polymorphic forms of spirapril hydrochloride
03/13/2008WO2007147899A3 Dha esters and use thereof in treatment and prevention of cardiovascular disease
03/13/2008WO2007135527A3 Benzimidazolyl compounds
03/13/2008WO2007126365A3 Further medical uses of antisecretory protein
03/13/2008WO2007112753A3 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
03/13/2008WO2007092270A3 Combination therapy for coronary artery disease
03/13/2008WO2007092065A3 Compounds and compositions as lxr modulators
03/13/2008WO2007089544A3 Biodegradable non-ophthalmic implants and related methods
03/13/2008WO2007082914A3 Method of diagnosis and method of treatment
03/13/2008US20080064853 Nervous system protein for use in treatment and prevention of nervous system and seizure disorders
03/13/2008US20080064753 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators
03/13/2008US20080064751 Utilizing lipoxin analogs; polyisoprenyl phosphate signaling inhibition
03/13/2008US20080064749 Lipoxin Analogs as Novel Inhibitors of Angiogenesis
03/13/2008US20080064747 Prevention of Neutrophil Recruitment
03/13/2008US20080064731 Remedy for chronic disease
03/13/2008US20080064728 Heterocyclic Compounds Useful as Dpp-Iv Inhibitors
03/13/2008US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate
03/13/2008US20080064719 Crf Receptor Antagonists And Methods Relating Thereto
03/13/2008US20080064707 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
03/13/2008US20080064704 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors
03/13/2008US20080064696 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
03/13/2008US20080064695 Neuronal nicotinic acetylcholine receptor modulators; such as ethyl 1-[4-(aminosulfonyl)phenyl]-5-(4-bromophenyl)-2-methyl-1H-pyrrole-3-carboxylate
03/13/2008US20080064688 Anti-inflammatory medicaments
03/13/2008US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea
03/13/2008US20080064682 1,5-diaryl-3-N-heterocycylcarbonylpyrazoles; antiagglomerants that do not inhibit cyclooxygenases; antiischemic agents
03/13/2008US20080064676 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity
03/13/2008US20080064668 Carbon 20 is substituted with methyl or cyclopropyl, carbon 16 is a single or double bond, and carbon 23 is a single, double, or triple bond; side effect reduction; vitamin deficiency; anticarcinogenic antiarthritic agents; immunotherapy; metabolic disorders; gene expression inhibition of ILT3
03/13/2008US20080064661 Dihydroxyl compounds and compositions for cholesterol management and related uses
03/13/2008US20080064654 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
03/13/2008US20080064652 Without inducing hypertriglyceridemia; injecting a therapeutic apoE nucleic acid that expresses a naturally-occurring apoE protein, associated with a liposome directly into the liver; the nucleic acid is a recombinant adeno-associated vector, a lentiviral, herpes viral, or retroviral vector
03/13/2008US20080064650 Therapeutic uses of inhibitors of RTP801L
03/13/2008US20080064637 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin
03/13/2008US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis
03/13/2008US20080063734 Schisandra extract; Ginseng extract; Radix ophiopogonis extract; and Salvia miltiorrhiza extract; water extraction, alcohol extraction; Scientifically Concentrated Traditional Chinese Medicine
03/13/2008US20080063711 Controlled Release Nisoldipine Compositions
03/13/2008US20080063707 Controlled release tablet formulations for the prevention of arrhythmias
03/13/2008US20080063690 Nut skin products
03/13/2008US20080063631 prophylaxis of vascular system disorders in mammals by administering apoptotic cells and/or bodies derived from leukocytes or lymphocytes
03/13/2008US20080063625 Method for Managing Cholesterol with a Serum-Free and Mitogen-Free Cytokine Mixture
03/13/2008US20080063624 administering compounds which bind to the chemokine receptors, such as 1,1'-[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane, optionally with colony stimulating factors, to effect regeneration of dead myocardium
03/13/2008CA2666686A1 Inhibitors of 5-lipoxygenase activating protein (flap)
1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 1595